When Lowering LDL Is Not Enough: Confronting Residual Inflammatory Risk After Myocardial Infarction
Numerous strategies have been studied to improve clinical outcomes after acute myocardial infarction (AMI), and the most firmly established is low-density lipoprotein (LDL) cholesterol-lowering therapy.Contemporary dyslipidemia guidelines therefore recommend intensive LDL-lowering after AMI, with an European Society of...